Filter by: patients
Home > Community Treatment Reports and Side Effects > VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone Treatment Report
What is VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone?

Induction therapy for multiple myeloma transplant and non-transplant candidates. Vincristine and Doxorubicin given by IV infusion on days 1 through 4; dexamethasone given by mouth on days 1 through 4, 9 through 12 and 17 through 20. One cycle is 20 days and is repeated every 28 days for 2-4 cycles.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 1 1 Efficacy_cant_tell

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 0

Reported Stop Reasons

Why Patients Stopped Taking VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 50%

See all 1 patient who’ve stopped taking VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone

Always
 0 0%
Usually
 1 100%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of VAD Vincristine, Doxorubicin (Adriamycin), Dexamethasone

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on February 11, 2012.